These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22040369)

  • 1. Modified Field stain - rapid viability test for Trichomonas vaginalis.
    Afzan MY; Sivanandam S; Suresh K
    J Appl Microbiol; 2012 Jan; 112(1):132-7. PubMed ID: 22040369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of various methods for the determination of viability of parasitic flagellates.
    Shaio MF; Chen JG; Chang FY
    Southeast Asian J Trop Med Public Health; 1987 Dec; 18(4):539-46. PubMed ID: 3502376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the effect of some medicinal plants on cultured Trichomonas Vaginalis.
    Selim MA; Fawzy EM; Abd El-Rahman EM; Abdel Hady RS; Badr MS; Abdel Hamed EF
    J Infect Dev Ctries; 2020 Jul; 14(7):793-799. PubMed ID: 32794472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Field's staining--a rapid stain for Trichomonas vaginalis.
    Afzan MY; Sivanandam S; Kumar GS
    Diagn Microbiol Infect Dis; 2010 Oct; 68(2):159-62. PubMed ID: 20846588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
    Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
    Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
    Malla N; Kaul P; Sehgal R; Gupta I
    Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
    Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
    J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between Mycoplasma hominis and Trichomonas vaginalis symbiosis in relation to metronidazole resistance.
    Mabaso N; Tinarwo P; Abbai N
    Parasitol Res; 2020 Dec; 119(12):4197-4204. PubMed ID: 33068149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
    da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
    Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.
    Korosh T; Bujans E; Morada M; Karaalioglu C; Vanden Eynde JJ; Mayence A; Huang TL; Yarlett N
    Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of
    Özel Y; Yılmaz U; Ünlü G; Özbilgin A; Ünlü M
    Turkiye Parazitol Derg; 2022 Mar; 46(1):7-13. PubMed ID: 35232699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Iron Status in the Early Progression of Metronidazole Resistance in Trichomonas vaginalis Under Microaerophilic Conditions.
    Argáez-Correa W; Alvarez-Sánchez ME; Arana-Argáez VE; Ramírez-Camacho MA; Novelo-Castilla JS; Coral-Martínez TI; Torres-Romero JC
    J Eukaryot Microbiol; 2019 Mar; 66(2):309-315. PubMed ID: 30047563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis.
    Natto MJ; Savioli F; Quashie NB; Dardonville C; Rodenko B; de Koning HP
    J Antimicrob Chemother; 2012 Apr; 67(4):933-43. PubMed ID: 22258922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase solubility studies and anti-Trichomonas vaginalis activity evaluations of metronidazole and methylated β-cyclodextrin complexes: Comparison of CRYSMEB and RAMEB.
    Malli S; Bories C; Ponchel G; Loiseau PM; Bouchemal K
    Exp Parasitol; 2018 Jun; 189():72-75. PubMed ID: 29730454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of iron ion on the growth of Trichomonas vaginalis in vitro].
    Yuan YQ; Xue CG
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Aug; 28(4):273-6. PubMed ID: 21137312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method to increase the viability of Trichomonas vaginalis in urine.
    Shafir SC; Sorvillo FJ; Upcroft JA; Upcroft P
    Sex Transm Dis; 2007 Jul; 34(7):485-7. PubMed ID: 17589330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro activity of metronidazole and garlic-based product (Tomex®) on Trichomonas vaginalis.
    Ibrahim AN
    Parasitol Res; 2013 May; 112(5):2063-7. PubMed ID: 23455944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.